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ABSTRACT 
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by rigidity, 
tremor, bradykinesia, and postural instability. Although dopaminergic therapies ameliorate many 
of the parkinsonian symptoms, especially in the early stages of the disease, as the disease 
progresses, efficacy of pharmacological therapy is diminished. Therefore, treatment of these 
symptoms continues to be a challenge. As a result, a significant number of rehabilitation strategies 
have been explored in order to improve the functional capability in this population. In the last two 
decades an interest in the role of physical exercise in the treatment of PD has emerged. In the 
current review we examine two modalities of exercise that have shown beneficial effects in 
improving motor action, balance, and gait in patients: aerobic training and resistance training. We 
conclude that although there are promising results suggesting the use of both modalities of 
exercises for the motor improvement in PD patients, the mechanism underlying these 
improvements are unknown and more studies with more defined designs and outcome measures 
are needed to further explore the impact of these two modalities of exercise on PD. 
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EJERCICIO AERÓBICO Y DE FUERZA  
EN LA ENFERMEDAD DE PARKINSON:  
UNA REVISIÓN NARRATIVA 
 
RESUMEN 
La enfermedad de Parkinson (EP) es un trastorno neurodegenerativo progresivo caracterizado por 
rigidez, temblor, bradicinesia e inestabilidad postural. Aunque las terapias dopaminérgicas mejoran 
muchos de los síntomas parkinsonianos, especialmente en las primeras etapas de la enfermedad, a 
medida que la enfermedad progresa, la eficacia de la terapia farmacológica disminuye. Por lo tanto, 
el tratamiento de estos síntomas sigue siendo un desafío. Como resultado, se ha explorado un 
número significativo de estrategias de rehabilitación para mejorar la capacidad funcional en esta 
población. En las últimas dos décadas he emergido un interés en el papel del ejercicio físico en el 
tratamiento de la EP. En la presente revisión examinamos dos modalidades de ejercicio que han 
demostrado efectos beneficiosos en la mejora de la acción motora, el equilibrio y la marcha de los 
pacientes: el entrenamiento aeróbico y el entrenamiento de fuerza. Concluimos que aunque existen 
resultados prometedores que sugieren el uso de ambas modalidades de ejercicios para la mejora 
motora en pacientes con EP, el mecanismo subyacente a estas mejoras es desconocido y se 
necesitan más estudios con diseños y variables bien definidas para explorar el impacto de estas dos 
modalidades de ejercicio sobre la EP. 
Palabras clave: enfermedad de Parkinson, ejercicio aeróbico, ejercicio de fuerza, factor 
neurotrófico derivado del cerebro 
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INTRODUCTION 
Parkinson's disease (PD) is considered the second most common 
neurodegenerative disorder after Alzheimer’s disease and it affects a 0.3% of 
the entire population in industrialized countries. Standardized incidence rates 
of reported PD are 10-20 per 100,000 people per year (Twelves, Perkins, & 
Counsell, 2003). The incidence varies in function of age, gender and ethnicity 
(Van Den Eeden, 2003). The incidence and prevalence are consistently higher in 
men than in women and the average age of onset in PD is established at about 
60 years old, so it is principally considered to be a disease of the elderly 
(Wirdefeldt, Adami, Cole, Trichopoulos, & Mandel, 2011). The number of 
patients with PD is expected to rise considerably in the coming decades due to 
ageing of the population and longer life expectancy. 
For two decades we have been witnessing an exceptional interest in the 
role of physical exercise in the treatment of PD. This interest is reflected in the 
exponential increase in the number of articles published on exercise and 
Parkinson's since 2004, which currently exceed 200 articles a year (in 
comparison with less than 50 papers before that year). Although no 
medications are proven to slow PD progression, several epidemiological studies 
seem to suggest a certain protective effect associated with the practice of 
exercise or physical activity. 
Sasco, Paffenbarger, Gendre and Wing (1992) were the first to suggest a 
beneficial relationship between physical activity and Parkinson. They 
conducted a case-control study of PD and physical exercise in a cohort of 
50,002 men who attended Harvard College (Cambridge, Mass) or the University 
of Pennsylvania (Philadelphia) between 1916 and 1950 and they followed up in 
adulthood for morbidity and mortality data. In adulthood, practice of moderate 
or heavy sports was linked to a reduced risk of developing PD, although a more 
precise analysis revealed that there was only a modest non-significant 
reduction in risk for subjects who performed a moderate amount of physical 
exercise, but this negative association disappeared at higher levels of physical 
expenditure. 
The findings of Sasco et al. (1992) have been replicated in subsequent 
epidemiologic studies in a total sample of approximately 400,000 subjects. We 
must highlight the study carried out with 43,368 participants in the Swedish 
National March Cohort, which reported a detailed description of physical 
activities including leisure, occupational, household and commuting activities 
at study enrolment (Yang et al., 2015). During 13 years of follow-up, 286 
subjects developed PD. Importantly, subjects who performed more than 6 
hours per week of physical activities when enrolled had a 43% lower risk of PD. 
However, these studies do not indicate that causality and other factors 
(such as lifestyle) could explain this relationship between physical activity and 
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prevalence of the disease. The 2018 report of the Movement Disorder Society 
on evidence-based medicine concluded there was "insufficient evidence" to 
support exercise as a treatment that prevents/delays disease progression (Fox 
et al., 2018). However, in the same report, exercise was classified as “likely 
efficacious". Exercise interventions included aerobic and resistance training 
among others. Therefore, although the beneficial effects of exercise on motor 
performance and general well-being in patients with PD may seem self-evident, 
the available body of scientific data in this domain is far from conclusive 
(LaHue, Comella, & Tanner, 2016). 
Among the multiple interventions of physical exercise in patients with PD, 
in recent years, two modalities of exercise have aroused interest to alleviate 
functional deficits in these patients: aerobic training and resistance training. In 
the current review, we will critically present the most relevant studies related 
to aerobic and resistance training in patients with PD. We will discuss the 
possible mechanisms that underlie the effects reported in these studies and we 
will suggest new approaches and research directions towards a more robust 
evidence of physical exercise in PD. Previously, we will make a brief 
introduction to PD as well as motor symptoms and fitness profile of patients 
with PD. 
 
A BRIEF INTRODUCTION TO PARKINSON'S DISEASE 
This section describes PD briefly, its motor symptoms as well as the 
physical fitness profile of patients suffering from this disease. This will provide 
the reader with a better understanding of the later sections in which the 




PD is a chronic degenerative process caused by the loss of dopaminergic 
neurons in the substance nigra. The first description of the disease was carried 
out by James Parkinson in 1817, in "An Essay on the Shaking Palsy" (Parkinson, 
1817). 
The aetiology is unknown, but it is believed that various genetic, 
environmental, as well as aging factors would be involved (Calne, 1989). The 
effect of all these factors is twofold, the loss of some selective neuronal 
populations, and the accumulation of abnormal proteins in the neuronal cells 
and neurites, forming the Lewy bodies, and the Lewy neurites respectively 
(Forno, 1996). Among the proteins that accumulate we can find alpha-synuclein, 
which is a major component of the Lewy bodies (Spillantini et al., 1997).  
The diagnosis of PD is clinical and it is based on the presence of various 
motor symptoms such as resting tremor, rigidity, bradykinesia, postural 
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alterations and freezing phenomena (Daniel & Lees, 1993). However, various 
non-motor symptoms (NMS) such as pain, depression, anxiety, fatigue, or 
cognitive alterations among other are also very frequently present in patients 
with PD, some appearing even before the development of motor symptoms 
(Stacy, 2009). In addition, these NMS are often very disabling, negatively 
conditioning the patient's quality of life (QoL) (Martinez-Martin, Rodriguez-
Blazquez, Kurtis, Chaudhuri, & NMSS Validation Group, 2011). The differential 
diagnosis of PD will be established fundamentally with other causes or diseases 
that cause parkinsonism, and occasionally, some structural and/or functional 
neuroimaging tests may be useful. 
There is no curative treatment at present for PD, although there are several 
drugs that improve the patient's symptoms both in the early stages of the 
disease and in those patients in a more advanced stage of the disease. Likewise, 
research is being carried out on possible therapies that produce an effector that 
modifies the course of the disease, in order to try to administer these therapies 
as early as possible with the intention of slowing down or delaying neuronal 
loss and the secondary symptoms caused by this loss (Schapira & Olanow, 
2004). Among the non-pharmacological therapies, surgery is currently a useful 
treatment option in some patients with advanced PD. On the other hand, 
another type of non-pharmacological therapies such as physiotherapy, physical 
exercise, speech therapy or cognitive stimulation are equally fundamental, in 
such a way that the most appropriate management of the disease is probably 
through a multidisciplinary approach (A’Campo, Wekking, Spliethoff-
Kamminga, Stijnen, & Roos, 2012). 
 
Motor features 
Motor features mainly comprise the four cardinal signs of PD (resting 
tremor, bradykinesia, rigidity and gait disturbances/postural instability), plus a 
widespread number of other motor abnormalities, called secondary motor 
symptoms, such as dysarthria, hypophonia, dysphagia or sialorrhoea, between 
others. In addition, flexed posture, gait disorders and freezing (motor blocks) 
have been included among classic features of PD (Shahed & Jankovic, 2007). 
 
a) Bradykinesia 
From a purist perspective, bradykinesia refers to slowness of movement, 
akinesia refers to poverty of spontaneous movement and the term hypokinesia 
means smaller amplitude of movement. However, in the literature the term 
bradykinesia tends to group all these motor features within the same construct. 
Bradykinesia encompasses difficulties with planning, initiating and executing 
movement with performing sequential and simultaneous tasks (Berardelli et al., 
2001). Bradykinesia is the motor sign that appears to correlate best with 
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degree of dopamine loss, due to the potential correlations with disease severity 
and response to treatment (Rodriguez-Oroz et al., 2009). 
 
b) Classic tremor  
Classic tremor is the most common and easily recognized symptom of PD. It 
is characterized by a low frequency rhythmic oscillation within a bandwidth of 
4 or 6 Hz that occurs at rest (Shahed & Jankovic, 2007). Hand-tremors are 
described as a supination-pronation tremor (‘pill-rolling’), but rest tremor in 
PD can also involve the lips, chin, jaw and legs. This type of tremor is 
pathophysiologically separated from the bradykinesia and rigidity, and the 
response of tremor to dopaminergic agents is less than in bradykinesia 
(Jellinger, 2012). It is now understood that classical tremor in PD is mediated 
by an abnormal oscillatory activity in an extensive motor network that involves 
the basal ganglia (BG), cerebellum, thalamus, and motor cortex (Hallett, 2014). 
 
c) Rigidity 
Rigidity is essentially an increase in resistance to passive movement. It was 
thought for years that rigidity is related to an enhancement of stretch reflex 
excitability (Cantello et al., 1991). It is known that rigid patients present an 
enhanced cortical excitability, coupled with the dopamine depletion and an 
increased BG output (Rodriguez-Oroz et al., 2009). However, how the BG 
changes associated with dopamine depletion modify the excitability of stretch 
reflex mechanisms has not been clarified. 
 
d) Postural stability and gait disorders 
Parkinson's patients have difficulties with balance in both sitting and 
standing and also to walk. When PD patients are standing, they adopt a flexed 
posture, with the body inclined slightly forward, with flexed knees and the 
arms in front of the body (Hanakawa et al 1999). PD gait is mainly 
characterized by the inability to generate an appropriate stride length (Morris, 
Iansek, Matyas, & Summers, 1996). Associated disturbances include a reduced 
gait speed, reduced arm swing (Wood, Bilclough, Bowron, & Walker, 2002), 
increased stride-to-stride variability, increased double limb support time, gait 
instability, stooping, difficulty turning, and forward-flexed posture (Ebersbach, 
Moreau, Gandor, Defebvre, & Devos, 2013; Huang et al., 2012). In advanced 
stages, more complex gait disturbances may often appear, including motor 
blocks, festination and disequilibrium. These entire gait features cause 
significant disability resulting in falls, immobility, and loss of independence 
(Bloem et al., 2016). Falls are considered one of the most serious complications 
of motion in PD, with an incidence of 70% during a 1-year follow-up, and 
recurrent falls occurred in approximately in 50% of the cases (Bloem, 
Miguel Fernández-del-Olmo; Jose Andrés Sanchez-Molina …   Aerobic and resistance … 
 
 
European Journal of Human Movement, 2018: 41, 149-174 154 
Hausdorff, Visser, & Giladi, 2004; Okuma, 2014). Disturbances of gait are one of 
the classical features in PD, which appear in almost all patients and often lead 
to loss of QoL (Ebersbach et al. 2013). Gait difficulties become progressively 
more levodopa-resistant, and thus are considered the hallmarks of the 
advanced stages in PD. Therefore the main focus of physical rehabilitation is to 
improve the gait deficits in PD. 
 
Physical inactivity in Parkinson’s disease 
The amount of physical activity is highly related with a wide list of health 
benefits and the lack of such activity is a major cause of chronic diseases. This is 
more dramatic when we refer to patients with PD, since the decrease of 
physical activity in these patients can worsen the symptoms associated to the 
disease. 
The knowledge of the physical behaviour profile in PD patients and the 
reasons to explain their physical activity are of importance since these will 
allow us to develop more rational strategies and programs to engage these 
patients in physical activities. However, the physical behaviour profile in PD is 
far from being known. Although, it has been suggested that Parkinson’s patients 
show lower levels of physical activity in comparison with healthy age-matched 
subjects, the number of studies describing the physical activity in PD patients is 
limited. A retrospective study (Fertl, Doppelbauer, & Auff, 1993) exploring the 
engagement of PD patients and controls in physical activities and sports 
reported that until the occurrence of the first symptoms, PD patients did not 
differ from controls. However, during the course of the disease, a striking 
reduction in physical activity (but not a complete abandonment of sports) was 
found. 
Chastin et al. (2010) analysed the sedentary behaviour in 17 PD patients 
and 17 age-matched controls during a period of 7 days using a wearable 
accelerometer to record bouts of sitting, lying, upright stance and walking. 
Their results showed that the total inactivity time was similar between groups 
although the bouts of inactivity tend to last longer than those of controls. The 
author suggests that with this behaviour patients try to conserve energy to 
maximize function, which is in agreement with other studies that showed a 
more spread out daily physical activity in PD patients than in healthy subjects 
(Busse, Pearson, Van Deursen, & Wiles, 2004; Rochester et al., 2006; van Hilten 
et al., 1993). Other studies using objective measures of physical activity did not 
find differences between PD patients and controls (Rochester et al., 2006; van 
Hilten et al., 1993). However, Busse et al. (2004) reported a significant lower 
number of steps during a 7 day period in PD patients in comparison with 
healthy subjects. In addition, the number of steps taken per day, as well as the 
average steps per minute in the most active hour was lower in individuals with 
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more severe PD, as defined by Hoehn & Yahr scale (Skidmore et al., 2008). Thus, 
although activity monitoring using accelerometry provides an objective method 
of quantifying activity in an ecological context (Rochester et al., 2006), the 
different variables recorded in each study (e.g. number of steps, number of 
walking periods, duration of walking periods) can account for these 
discrepancies between the mentioned studies. Moreover, several other physical 
activities can be more difficult to quantify using these activity monitors (van 
Nimwegen et al., 2011). 
An alternative and complementary approach for the study of physical 
activity is the use of validated physical activity questionnaires. Using the LASA 
(Longitudinal Aging Study Amsterdam) Physical Activity Questionnaire 
(LAPAQ), van Nimwegen et al. (2011) compared the physical activity between 
699 PD patients and 1959 healthy controls in the largest study of this kind 
conducted in PD patients so far. The LAPAQ (Stel et al., 2004) is a relative new 
physical activity questionnaire for older persons based on both the Modified 
Baecke Questionnaire for Older Adults (Voorrips, Ravelli, Dongelmans, 
Deurenberg, & Van Staveren, 1991) and the Zutphen Physical Activity 
Questionnaire (Caspersen, Powell, & Christenson, 1985). The LAPAQ covers 
frequency and duration of different activities during the previous 2 weeks such 
as walking outside, cycling, gardening, light and heavy household activities, and 
a maximum of two sport activities (Stel et al., 2004). The results of this study 
showed that PD patients were physically less active with a reduction of 29% 
compared to controls. In addition, the loss of time spent on activities was most 
obvious in patients with greater disease severity (van Nimwegen et al., 2011). 
Most of the above-mentioned studies support the hypothesis of a 
significant reduction of physical activity in PD patients. Several factors have 
been explored in order to explain this reduction. Fatigue, motor disabilities and 
disease severity have been the logical factors. 
Fatigue has been defined as an intense feeling of tiredness, lack of energy 
and a feeling of being exhausted. Fatigue is a very common and severe problem 
in PD and, with the exception of its epidemiology, the nature and aetiology of 
this symptom is unknown (Friedman & Abrantes, 2012). Fatigue affects 
approximately two thirds of patients and it is reported as the most severe 
symptom in 15-33% of patients, and as one of the three worst symptoms in 50% 
of patients. Although fatigue is associated with depression and sleep disorders, 
it is also common in patients who do not suffer from these conditions. Neither 
does it seem to be directly associated with a greater severity of the disease. 
The association found between fatigue and dynamic activity suggests that 
patients who experience higher levels of fatigue are less physically active. 
However, the total explained variance of dynamic activity by fatigue alone was 
small, suggesting that fatigue is only a minor factor in the complex of 
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behavioural aspects that affect the amount of physical activity in patients with 
PD (Elbers et al., 2009). While disease severity, gait and disability in daily living 
predicted part of the inactivity, a portion of the variance remained unexplained, 
suggesting that additional determinants may also affect daily physical activities 
in PD (van Nimwegen et al., 2011). 
Interestingly, when PD patients were classified as “exercisers” or 
“nonexercisers” based on their responses to the Stages of Readiness to Exercise 
Questionnaire, self-efficacy rather than disability was most strongly associated 
with regular exercise. Patients with higher exercise self-efficacy were more 
likely to engage in exercise compared with those with low exercise self-efficacy, 
regardless of the disease severity (Ellis et al., 2011). 
 
Cardiovascular system in Parkinson’s disease 
Several studies have examined aerobic capacity in subjects with PD. 
Maximal or peak aerobic capacity (VO2peak) is evaluated during a maximal 
effort graded exercise test usually conducted on a cycling ergometer or a 
treadmill (Katzel et al., 2011; Protas, Stanley, Jankovic, & MacNeill, 1996). 
Measurement of VO2peak is reliable and repeatable in subjects with mild to 
moderate PD, thereby validating the use of this parameter for assessing the 
effects of exercise interventions on cardiorespiratory fitness (Katzel et al., 
2011). Overall, the results for VO2peak in PD have been mixed. Some studies 
reported VO2peak values that were generally 20% lower in PD than in age-
matched controls (Katzel et al., 2011), while others find not differences 
between those groups (Canning, Alison, Allen, & Groeller, 1997; Saltin & Landin, 
1975). It is possible that substantial heterogeneity in the VO2peak and walking 
speeds in PD subjects account for this discrepancy across studies. Nevertheless, 
it seems that there is not correlation between disease severity and VO2peak, at 
least for individuals with mild to moderate PD (Canning et al., 1997; 
Christiansen, Schenkman, McFann, Wolfe, & Kohrt, 2009). 
Interestingly, one study indicated that patients with PD were unable to 
exercise as long as the age-matched controls before reaching VO2max, even 
though there were no significant differences in VO2max between both groups 
(Stanley, Protas, & Jankovic, 1999). This could suggest that individuals with PD 
may be less efficient during exercise (Stanley et al., 1999). This is in line with 
the findings that indicate that walking economy, defined as the rate of oxygen 
consumed per distance during walking, is less efficient in PD patients compared 
with healthy subjects (Christiansen et al., 2009). Alterations in walking 
performance, such as increased stride length variability and reduced gait speed, 
and changes related to PD motor symptoms of tremor, rigidity, hypokinesia, 
and postural instability could increase the total energy cost in this population.  
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Cardiovascular autonomic dysfunction is a non-motor feature in PD, 
affecting 40% of Parkinson’s patients in advanced stages, but it can also be 
present in patients in earlier stages (Velseboer, de Haan, Wieling, Goldstein, & 
de Bie, 2011). Also known as orthostatic hypotension or autonomic failure, this 
autonomic dysfunction can lead to sudden reductions in blood pressure during 
daily activities significantly affecting the QoL. Few studies have explored if 
blood pressure increases appropriately during exercise or if exercise 
accentuates orthostatic hypotension in PD patients with autonomic dysfunction, 
which is of relevance for safety reasons (Low et al., 2014; Mavrommati et al., 
2017). The current available literature indicates that, in PD patients with 
autonomic dysfunction, exercise-induced hypotension can occur with the 
magnitude of the exercise response being related to the severity of the 
autonomic dysfunction (Low, Vichayanrat, Iodice, & Mathias, 2014). In addition, 
exercise does not appear to worsen orthostatic hypotension in this sample of 
Parkinson’s patients (Low et al., 2014). However, in this study the exercise test 
protocol involved supine cycling and thus, it remains to be explored whether 
those results can be replicated in other kind of exercises. In a randomized 
controlled trial (Mavrommati et al., 2017), PD subjects without autonomic 
dysfunction participated in an exercise programme of  48  sessions  over  a  24-
week  period  (2 sessions per week). Each session, which lasted 60 min, 
consisted of the following: 30 min of aerobic training (plus an initial 10 min 
warm-up) [55%–85% age-predicted HRmax (220 - age)] followed by 30 min of 
resistance training (resistance was selected so that 10 repetitions could be 
performed). The results indicate that i) PD patients present lower elevations in 
heart rate and blood pressure during exercise; ii) they improved movement in 
response to exercise; iii) there was a trend to reduce HR in response to training, 
suggesting an improved efficiency of the cardiovascular system; and iv) there 
was a positive effect on reducing blood pressure after 3 and after 6 months. The 
authors suggest that PD patients have a reduced aerobic response during 
exercise and rely on anaerobic metabolism for their capacity gains. In addition, 
cardiovascular changes are normal whereas respiratory changes are not, 
indicating cardiovascular adaption to exercise occurs in the absence of effects 
on metabolic systems. 
 
Muscle strength in Parkinson’s disease 
Several reviews have addressed the so-called muscle weakness (Cano-De-
La-Cuerda, Pérez-De-Heredia, Miangolarra-Page, Muñoz-Hellín, & Fernández-
De-Las-Peñas, 2009; Falvo, Schilling, & Earhart, 2008) and detailed information 
of the studies included in those reviews is available for the reader. The ability 
to exert force in patients with PD has not been sufficiently explored although 
there is agreement that certain manifestations of strength are impaired in this 
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disease. In fact, some authors suggest that a loss of muscle strength could be a 
primary symptom inherent to the disease (Kakinuma, Nogaki, Pramanik, & 
Morimatsu, 1998), although more studies are needed to confirm this assertion.  
Most of the studies comparing the force production capabilities between 
patients with PD and healthy subjects agree in showing a reduction in the rate 
of force development in subjects with PD (Pääsuke et al., 2004; Pääsuke, Mõttus, 
Ereline, Gapeyeva, & Taba, 2002). Persons with mild-to-moderate PD display 
disparities in the rate of force development, even without deficits in maximal 
force (Hammond, Pfeiffer, LeDoux, & Schilling, 2017).  
Unlike the rate of force development (RFD), the effect of the PD on the 
maximum voluntary contraction (MVC) is not clear (Falvo et al., 2008). There 
are studies that indicate a lower MVC in these patients (Inkster, Eng, MacIntyre, 
& Stoessl, 2003; Pääsuke et al., 2004, 2002) while other studies show no 
differences in comparison with healthy age-matched subjects (Hammond et al., 
2017). Recently, it has been reported that PD patients not only show lower 
maximal force production but also show higher force variability in the hip 
flexors, ankle plantar flexors and dorsiflexors (muscles that are critical for 
effective ambulation) in comparison with healthy age-matched subjects 
(Skinner, Christou, & Hass, 2019).  
The inability to produce force at a rate comparable to controls has been 
suggested to be a downstream effect of central dysfunction of the motor 
pathway in PD (Hammond et al., 2017). This could also be true for the MVC. 
Using the interpolated twitch test, voluntary activation level and twitch force 
were quantified on the quadriceps muscle by exercise-induced changes in MVC 
(Huang et al., 2017). The results of this study showed that voluntary activation 
level was lower in the PD group than in the healthy control group, suggesting 
that weakness originated from central fatigue in the PD group. This is in line 
with a previous study showing that Parkinson fallers are affected by strength 
impairments arising from the central nervous system and not from the 
peripheral muscle contractile capacity, even at early stages of the disease and 
young age (Moreno Catalá, Woitalla, & Arampatzis, 2013). 
It is important is to emphasize the role that both the maximum strength 
and RFD can play in situations of imbalance, fundamentally at the level of the 
lower extremities. High RFD is crucial in order to achieve high levels of force 
and speed during the movement, since the maximal RFD determines the force 
that can be generated in the early phase of muscle contraction (Aagaard, 
Simonsen, Andersen, Magnusson, & Dyhre-Poulsen, 2002) while sufficient force 
would be crucial to modify the center of mass over the base of support. 
Therefore, optimal maintenance of the maximum force levels and RFD is even 
more relevant in Parkinson's patients, who have a high incidence of falls. 
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Whether resistance training is the ideal intervention to achieve those goals is 
discussed in a latter section. 
 
AEROBIC TRAINING IN PARKINSON’S DISEASE 
Aerobic exercise (also known as cardio) is physical exercise of low to high 
intensity that depends primarily on the aerobic energy-generation process. 
Under this premise any type of exercise that is in this range of intensity could 
be considered aerobic exercise. For example, in a review (Shu et al., 2014) on 
the effect of aerobic exercise in PD it was concluded that aerobic exercise 
showed immediate beneficial effects in improving motor action, balance, and 
gait in patients with PD. However, this review included activities such as 
dancing, tai chi or gait training with rhythmic support, activities that may 
involve other potentially therapeutic mechanisms in this pathology. This is of 
relevance to objectively examine the impact of aerobic exercise and isolate it 
from the effect that other potential players may have on the motor treatment of 
this pathology. In fact, the authors of the revision recognize that it is difficult to 
extract accurate information regarding the contribution of aerobic exercises in 
patients with PD because multiple exercise therapies were often involved (Shu 
et al., 2014). 
One of the most relevant studies on aerobic exercise in PD has been a 
randomized clinical study of 3 types of exercise (Shulman et al., 2013) 
performed in a total of 77 patients distributed in a group of lower-intensity 
treadmill training (reaching up to 50 min at 40% to 50% of heart rate reserve), 
higher-intensity treadmill training (up to 30 min at 70% to 80% of heart rate 
reserve) and stretching and resistance training. For the treadmill training 
groups, mechanical work was equated. After 36 sessions of training distributed 
in 3 weekly sessions for 3 months, it was found that each type of exercise 
resulted in different types of benefits. Interestingly, the lower-intensity 
treadmill exercise was the single most effective training exercise for gait and 
fitness. This study leads to interesting questions such as the specificity of the 
exercise, or how different modalities of exercise can lead to different kind of 
improvements. In addition, it seems that to improve the gait in PD subjects, 
high intensities of training are not necessarily needed. We should emphasize 
that the training of the gait was conducted walking on a treadmill, so it is 
questionable that these findings are reproducible by walking on the ground. In 
fact, in a study from our lab, 22 PD patients were randomly assigned to a 
treadmill or overground gait training group (Bello et al., 2013). After 15 
training sessions all subjects improved their walking speed. However, the 
treadmill training program, but not the overground program, led to an 
improvement in the stride length at the preferred and maximal walking speed. 
This study provides evidence of a specific therapeutic effect of treadmill 
Miguel Fernández-del-Olmo; Jose Andrés Sanchez-Molina …   Aerobic and resistance … 
 
 
European Journal of Human Movement, 2018: 41, 149-174 160 
training on Parkinsonian gait and questions that the effects reported in the 
mentioned study are the result of an aerobic training in itself. 
The rationale of using aerobic exercise in patients with PD would be their 
possible contribution to the neuroplasticity of the nervous system. By 
neuroplasticity we can understand the brain's ability to form and modify 
synaptic connections. There are numerous studies that have addressed the 
effect of aerobic exercise on neuroplasticity, although most of these have been 
carried out with animals [see review in Ahlskog (2018)]. Those studies have 
shown an improvement in the performance of tasks related to spatial memory 
and the recognition of objects after an aerobic training (i.e. 1 hour of treadmill 
exercise for 5 months) (Rhyu et al., 2010). Changes in hippocampal 
neurogenesis (increased neurons) in rats after long-term aerobic training have 
been documented, as well as an increase in brain factors mediating the 
neuroplasticity process (Gibbons et al., 2014).  
Perhaps the most studied factor has been the brain-derived neurotrophic 
factor (BDNF), with numerous studies that have linked the practice of physical 
exercise with an increase in BDNF levels [see review in De Assis, Gasanov, de 
Sousa, Kozacz, & Murawska-Cialowicz (2018)]. This is of relevance since it is 
well established that in PD patients there is a depletion of BDNF in blood serum, 
which typically helps support existing neurons and encourages the growth of 
synapses (Scalzo, Kümmer, Bretas, Cardoso, & Teixeira, 2010). There have been 
attempts to restore this depletion via directly infusing BDNF although they 
have been unsuccessful as BDNF is not able to cross the blood–brain barrier 
(Nagahara & Tuszynski, 2011). Therefore, a potential alternative way to restore 
BDNF would be through exercise, which has been shown to increase BDNF 
levels in the blood serum (Da Silva, Domingues, De Carvalho, Allodi, & Correa, 
2016; Gerecke, Jiao, Pagala, & Smeyne, 2012; Tang, Chu, Hui, Helmeste, & Law, 
2008). However, several studies have shown an increase in BDNF serum levels 
in PD subjects after exercise (Angelucci et al., 2016; Frazzitta et al., 2014) but 
other studies indicate that although exercise can improve PD patient’s motor 
deficits, it does not slow down or stop the progressive aspect of PD [see review 
in Bega, Gonzalez-Latapi, Zadikoff, & Simuni (2014)]. Therefore, while exercise 
would be beneficial to PD patients for controlling the motor symptoms, it does 
not necessarily facilitate restoration of the nigrostriatal pathway (Churchill et 
al., 2017). This interesting dichotomy suggests that exercise is facilitating 
motor recovery through either other neurotransmitter circuits or non-neuronal 
mechanisms and this could be allowing the brain to compensate for the 
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RESISTANCE TRAINING 
The effectiveness of resistance training in improving motor symptoms in 
patients with PD has been investigated in several systematic reviews (Falvo et 
al., 2008; Ramazzina, Bernazzoli, & Costantino, 2017; Roeder, Costello, Smith, 
Stewart, & Kerr, 2015). Resistance training performed against external 
resistance is well tolerated and appears to be a suitable physical activity to 
improve both physical parameters and QoL parameters of PD subjects. 
However, these findings should be interpreted with caution due to the 
relatively high risk of bias of most studies (Roeder et al., 2015). In addition, 
only a few selected studies assessed the improvement of muscle strength, 
making it difficult to establish a correlation between resistance training and the 
improvements made (Ramazzina et al., 2017; Shu et al., 2014). Moreover, high 
variation was evident across studies in the training durations, frequencies, 
modes, volumes, intensities and progressions. This makes it difficult to identify 
characteristics of effective resistance training interventions and to provide 
evidence-based guidelines at the present time (Roeder et al., 2015). Details of 
training doses in those studies can be found in Roeder et al. (2015). 
The longest intervention is reported in the study of Corcos  et al. (2013), in 
which they assessed the effects of 2 years of progressive resistance training 
(PRET) in mild-to-moderate PD patients. PRET was significantly more 
efficacious at improving movement velocity and isometric muscle strength than 
a multimodal exercise regime that used stretching, balance, breathing, and non-
progressive resistance exercises. Further analysis from the same cohort 
published in later publications indicated that PRET partially restores the 
triphasic electromyographic pattern and improves movement velocity (David 
et al., 2016). Additionally, the improvement in the triphasic electromyographic 
pattern and muscle strength was significantly associated with improvement in 
peak velocity. The authors suggest that that resistance exercise can drive 
neurophysiological changes that underlie the improvement in movement 
velocity in PD (David et al., 2016). Interesting, strength gains did not appear to 
transfer to gait, even though both PRET and the multimodal exercise program 
improved off-medication fast gait velocity and improved cadence in all 
conditions evaluated (off-/on-medication, comfortable/fast speed) (Rafferty et 
al., 2017). 
Recently, new modalities of resistance training such as instability 
resistance training (Silva-Batista et al., 2017) or high-speed resistance training 
(Ni & Signorile, 2017) have been used in patients with PD. The former modality 
seems to be more effective than traditional resistance training in improving 
neuromuscular parameters such as root mean square and mean spike 
frequency of electromyographic signal, peak torque and rate of torque 
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development of the knee extensors and plantarflexors during maximum 
ballistic voluntary isometric contractions (Silva-Batista et al., 2017).  
Different reasons have been pointed out that justify introducing resistance 
training in patients with PD. In PD, motor cortices are not fully activated due to 
the secondary abnormal drive from the BG to the thalamus (Albin, Young, & 
Penney, 1989). This impaired cortical activation can lead to an inability to 
sufficiently activate motoneuron pools, thereby affecting recruitment and 
discharge rate (Falvo et al., 2008). Therefore, resistance training may be of 
therapeutic value to individuals with PD to enhance neural drive to the agonist 
as well as decrease coactivation, both contributing to improved strength and 
movement control (Falvo et al., 2008). However, it is questionable that 
resistance training may act on the same cortical mechanism that is impaired in 
PD, especially when it has been reported that resistance training changes the 
functional properties of spinal cord circuitry in humans, but does not 
substantially affect the organisation of the motor cortex (Carroll, Riek, & Carson, 
2002). Another argument to support the use of resistance training in PD is the 
possible relationship of strength levels and performance in daily activities such 
as walking or getting up from a chair. Although numerous studies have shown 
that increased strength translates into gait improvements in healthy elderly 
subjects, this has not been shown conclusively in patients with PD. Therefore, 
the rationale of the use of resistance training in EP is still under debate. 
 
NEW APPROACHES AND RESEARCH DIRECTIONS 
The study of the effects of physical exercise, not only for the resistance and 
aerobic training, in PD presents numerous challenges that make it difficult to 
know the impact of exercise on the prevention / treatment of the disease and 
also the mechanisms underlying these possible effects. 
 
Randomized controlled trials 
The realization of clinical randomized controlled trials to explore whether 
exercise slows down the neurological deterioration that occurs in PD is very 
complex due to several factors such as the relatively slow deterioration of the 
patients, which implies excessively long periods of intervention and monitoring 
(Ahlskog, 2018). This makes it difficult for measure outcomes not to be 
contaminated by changes in medication, changes that are relatively frequent in 
many patients. In addition, long periods of intervention also demand adherence 
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Specific vs generalized benefits 
Exercise interventions have been effective in improving several gait 
parameters and, as a result, the QoL of PD patients. However, these 
improvements may have been the result of a general beneficial effect of 
exercise rather than a specific improvement of the motor symptomology in this 
pathology. Without undermining the importance of these improvements for the 
functionality of these patients, it is necessary to know which type of exercise 
has specific effects on the symptoms of this disease in order to develop more 
effective interventions. For instance, we have previously mentioned that gait 
pattern in PD subjects is characterized by a specific deficit of the internal 
regulation of the stride length, while the cadence control is intact (Morris, 
Iansek, Matyas, & Summers, 1994). In other words, for an equal value in speed 
or cadence the stride length is always lower in PD subjects. Therefore, the 
regulation of stride length must represent one of the main goals in 
rehabilitation interventions in PD subjects. However, most of the studies that 
evaluate the efficacy of rehabilitation and exercise interventions use, 
independently, changes in stride length, cadence or speed as the main outcome 
measures (Kwakkel, de Goede, & van Wegen, 2007). Thus, although, increases 
in gait speed may reflect a functional improvement, these do not necessarily 
reflect an amelioration of PD symptomatology. In addition, due to the age-
associated progressive loss of physical function, it is difficult to elucidate which 
rehabilitation approach has a specific impact in PD rather than a generalized 
benefit from exercise (Ambrus, Sanchez, & Fernandez-Del-Olmo, 2018). We 
propose that the study of the stride length-cadence may help to establish the 
specific therapeutic effect of an intervention, in order to optimize the 
rehabilitation strategy (Ambrus et al., 2018). Therefore, the selection of 
appropriate outcome measures is another relevant issue in the study of the 
effects of physical exercise in PD. 
 
Outcome measures 
The heterogeneity of motor symptoms in PD and their effects on the 
functional capacity of the patients with PD leads to a large number of variables 
and measurement protocols that make the interpretation of results very 
complex. To establish the outcome measures in a study must depend on 
whether the objective is simply to capture disease burden, or to use it as a 
surrogate marker of pathology (Lord, Galna, & Rochester, 2013). This highlights 
the need for interventional studies to indicate a priori the expected results for 
the primary and secondary outcome measures.  
Several previously cited reviews in the current manuscript indicate that 
only a few selected studies assessed the improvement of muscle strength 
(Ramazzina et al., 2017) or cardiovascular measures in response to resistance 
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training and aerobic training programs, respectively. Despite the encouraging 
results of those studies, it is difficult to establish a correlation between 
resistance and aerobic training and the improvements made and to clarify the 
nature of those improvements. 
 
Cued training 
Martin in 1967 was the first to prove how a series of coloured lines 
arranged on the floor perpendicular to the direction of walking improved the 
ambulatory characteristics of PD patients. The first therapeutic application was 
conducted by Thaut  et al. (1996) who subjected patients with PD to a training 
program consisting of walking in synchrony with a rhythmic auditory stimulus. 
The training lasted for 3 weeks, after which there was an improvement in the 
speed, amplitude and cadence of the gait and muscle activation pattern. In 
addition, this improvement was significantly greater in comparison to a group 
of patients who performed the same training, but without rhythmic auditory 
stimulation. Similar results have been obtained in numerous studies that have 
indicated an immediate, short- and long-term positive effect in the gait of PD 
patients after interventions that used visual signals, rhythmic auditory signals 
or proprioceptive cues (by walking on a treadmill). It has been suggested that 
external sensory cues can provide the necessary trigger in PD to switch from 
one movement component to the next, bypassing defective internal 
pallidocortical projections, possibly via the lateral premotor cortex, which 
controls externally guided movements (Alexander, DeLong, & Strick, 1986; 
Penney & Young, 1983). It is important to note that most of the studies that 
assess the impact of aerobic exercise on PD have been performed using a 
treadmill. This makes us question whether the effects on the progress reported 
in these studies are due to aerobic work and not to the unique effects of the 
treadmill and thus, other intervention strategies are necessary to evaluate the 
effect of aerobic training. 
 
CONCLUSIONS 
Physical exercise in the form of aerobic training or resistance training 
seems to be effective in the motor treatment and in improving the functional 
capacity of patients with PD, although the mechanisms underlying these 
improvements are still unknown. More studies are needed with more defined 
designs and outcome measures to further explore the impact of these two 
modalities of exercise on PD. 
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